Envista (NYSE:NVST - Free Report) had its price objective decreased by Morgan Stanley from $20.00 to $19.00 in a research note released on Thursday morning,Benzinga reports. Morgan Stanley currently has an equal weight rating on the stock.
NVST has been the subject of several other research reports. Wells Fargo & Company upped their price target on Envista from $20.00 to $21.00 and gave the stock an "equal weight" rating in a report on Thursday, February 6th. Jefferies Financial Group increased their target price on shares of Envista from $20.00 to $22.00 and gave the company a "hold" rating in a report on Thursday, January 23rd. Needham & Company LLC restated a "hold" rating on shares of Envista in a report on Thursday. Piper Sandler increased their price objective on shares of Envista from $17.00 to $18.00 and gave the company a "neutral" rating in a research note on Monday, February 3rd. Finally, Mizuho assumed coverage on Envista in a research note on Wednesday, December 4th. They issued an "underperform" rating and a $20.00 target price on the stock. Two analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and an average target price of $20.18.
Check Out Our Latest Analysis on NVST
Envista Stock Down 4.8 %
NYSE:NVST traded down $0.89 on Thursday, hitting $17.55. The stock had a trading volume of 3,168,325 shares, compared to its average volume of 2,287,146. The company has a quick ratio of 1.76, a current ratio of 2.04 and a debt-to-equity ratio of 0.44. Envista has a 52 week low of $15.15 and a 52 week high of $23.00. The business's fifty day moving average is $20.22 and its 200 day moving average is $19.70. The company has a market cap of $3.02 billion, a PE ratio of -2.70, a P/E/G ratio of 1.27 and a beta of 1.33.
Envista (NYSE:NVST - Get Free Report) last posted its earnings results on Wednesday, February 5th. The company reported $0.24 earnings per share for the quarter, topping analysts' consensus estimates of $0.23 by $0.01. Envista had a negative net margin of 44.56% and a positive return on equity of 3.86%. On average, equities research analysts expect that Envista will post 1 EPS for the current fiscal year.
Institutional Trading of Envista
A number of institutional investors have recently modified their holdings of NVST. Huntington National Bank raised its holdings in Envista by 97.8% during the 3rd quarter. Huntington National Bank now owns 1,919 shares of the company's stock valued at $38,000 after acquiring an additional 949 shares during the period. Venturi Wealth Management LLC raised its stake in shares of Envista by 528.4% during the 4th quarter. Venturi Wealth Management LLC now owns 1,948 shares of the company's stock valued at $38,000 after purchasing an additional 1,638 shares during the period. GAMMA Investing LLC raised its stake in shares of Envista by 30.5% during the 4th quarter. GAMMA Investing LLC now owns 2,304 shares of the company's stock valued at $44,000 after purchasing an additional 538 shares during the period. Thurston Springer Miller Herd & Titak Inc. purchased a new stake in Envista during the 4th quarter worth about $53,000. Finally, Mitsubishi UFJ Trust & Banking Corp bought a new position in Envista in the 4th quarter worth about $86,000.
About Envista
(
Get Free Report)
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.
Featured Articles
Before you consider Envista, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Envista wasn't on the list.
While Envista currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
